The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | J | Antiinfectives for systemic use | |
| 2 | J01 | Antibacterials for systemic use | |
| 3 | J01X | Other antibacterials | |
| 4 | J01XE | Nitrofuran derivatives |
| Code | Title | |
|---|---|---|
| J01XE01 | Nitrofurantoin | |
| J01XE02 | Nifurtoinol | |
| J01XE03 | ||
| J01XE51 |
| Active Ingredient | Description | |
|---|---|---|
| Furazidin |
|
|
| Nitrofurantoin |
Nitrofurantoin is a broad spectrum antibacterial agent, active against the majority of urinary pathogens. It is bactericidal in renal tissue and throughout the urinary tract. The wide range of organisms sensitive to the bacterial activity include Escherichia coli, Enteroccus faecalis, Klebsiella species, Enterobacter species, Staphylococcus species: (e.g. S. aureus, S. saprophyticus, S. epidermidis). |
| Title | Information Source | Document Type | |
|---|---|---|---|
| MACROBID Capsule | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
| MACROBID Prolonged-release capsule | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| MACRODANTIN Capsule | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
| NITROFURANTOIN Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
